Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
SpringWorks Therapeutics Inc. (3.6%) (SWTX – $46.99 – NASDAQ) is a commercial stage biotech focused on the treatment of various forms of cancer and rare diseases. After several months...
— Mario J. Gabelli, CFA, Willis Brucker
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on SpringWorks Therapeutics, Inc.
No other institutional pitches found for this ticker yet.